Dow Inc. shares have rallied 39% year to date, outperforming the Zacks Chemicals Diversified industry's 23.6% gain and the S&P 500's roughly 10% increase. The company is benefiting from cost-reduction and productivity improvement efforts, strategic expansion in high-growth markets, and feedstock advantages. Dow is targeting $1 billion in cost cuts, with more than $400 million in benefits realized in 2025 and the remainder expected by 2026. Its 'Transform to Outperform' initiative aims for at least $2 billion in near-term operating EBITDA improvement, with roughly $500 million in EBITDA benefits expected in 2026 and about $1.1 billion in total self-help benefits this year. The company also noted strong positive momentum from recent pricing actions and supportive improvements in operating rates.
Dow IncCost-cutting and productivity improvements driving EBITDA growth, with $1B cost reduction target and $2B EBITDA improvement initiative.
Nucor Corp
Albemarle Corp
LB Foster Company